Clinical Trials

Phase III Randomized Trial of Concurrent Chemoradiotherapy with or without Atezolizumab in Localized Muscle Invasive Bladder Cancer


Study ID
S1806

NCT Number
NCT03775265 (Click on the NCT number for more information about the trial)

Research Study Number
2019-0672

Principle Investigator
Dr. Alter, Robert

Phase
III

Sponsor
SWOG


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now